Sec Form 13D Filing - Tamarack Advisers LP filing for STREAMLINE HEALTH SOLUTIONS INC. (STRM) - 2023-06-22

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D
(Amendment No. 3)

Under the Securities Exchange Act of 1934


Streamline Health Solutions Inc.
(Name of Issuer)

Common Stock, $0.01 par value
(Title of Class of Securities)

86323X106
(CUSIP Number)

Melissa Dehn
305 SE Chkalov Dr., Suite 111-322
Vancouver, WA  98683
(360) 737-4153
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

06/15/2023
(Date of Event which Requires
Filing of this Statement)

If the filing person has previously filed a statement on
Schedule 13G to report the acquisition which is the subject of
this Schedule 13D, and is filing this schedule because of
240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following
box. [X].

Note:  Schedules filed in paper format shall include a signed
original and five copies of the schedule, including all
exhibits. See 240.13d-7 for other parties to whom copies are to
be sent.

*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to
the subject class of securities, and for any subsequent
amendment containing information which would alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18
of the Securities Exchange Act of 1934 ("Act") or otherwise
subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the
Notes).


CUSIP No. 86323X106	SCHEDULE 13D	Page 2 of 10



 1   Name of Reporting Person
     Justin J. Ferayorni
     IRS Identification No. of Above Person
     (entities only)

 2   Check the Appropriate Box if a Member of a Group*  (a) [ ]
                                                        (b) [ ]

 3   SEC USE ONLY

 4   Source of Funds                                         WC

 5   Check Box if Disclosure of Legal Proceedings
     is Required Pursuant to Items 2(d) or 2(e)             [ ]

 6   Citizenship or Place of Organization
     United States Citizen

     NUMBER OF         7   Sole Voting Power           5,514,515
     SHARES
     BENEFICIALLY      8   Shared Voting Power         -0-
     OWNED BY EACH
     REPORTING         9   Sole Dispositive Power      5,514,515
     PERSON
     WITH             10   Shared Dispositive Power    -0-

11   Aggregate Amount Beneficially Owned by Each Reporting
Person
     5,514,515

12   Check Box if the Aggregate Amount in Row 11 Excludes
Certain Shares
     [ ]

13   Percent of Class Represented by Amount in Row 11
     9.4%

14   Type of Reporting Person
     IN



CUSIP No. 86323X106	SCHEDULE 13D	Page 3 of 10



 1   Name of Reporting Person
     Tamarack Capital GP, LLC
     IRS Identification No. of Above Person	47-4492240
     (entities only)

 2   Check the Appropriate Box if a Member of a Group*  (a) [ ]
                                                        (b) [ ]

 3   SEC USE ONLY

 4   Source of Funds                                         WC

 5   Check Box if Disclosure of Legal Proceedings
     is Required Pursuant to Items 2(d) or 2(e)             [ ]

6   Citizenship or Place of Organization
     Delaware

     NUMBER OF         7   Sole Voting Power           4,930,882
     SHARES
     BENEFICIALLY      8   Shared Voting Power         -0-
     OWNED BY EACH
     REPORTING         9   Sole Dispositive Power      4,930,882
     PERSON
     WITH             10   Shared Dispositive Power    -0-

11   Aggregate Amount Beneficially Owned by Each Reporting
Person
     4,930,882

12   Check Box if the Aggregate Amount in Row 11 Excludes
Certain Shares
     [ ]

13   Percent of Class Represented by Amount in Row 11
     8.4%

14   Type of Reporting Person
     HC



CUSIP No. 86323X106	SCHEDULE 13D	Page 4 of 10



 1   Name of Reporting Person
     Tamarack Advisers, LP
     IRS Identification No. of Above Person	47-4492240
     (entities only)

 2   Check the Appropriate Box if a Member of a Group*  (a) [ ]
                                                        (b) [ ]

 3   SEC USE ONLY

 4   Source of Funds                                         WC

 5   Check Box if Disclosure of Legal Proceedings
     is Required Pursuant to Items 2(d) or 2(e)             [ ]

6   Citizenship or Place of Organization
     Delaware

     NUMBER OF         7   Sole Voting Power           4,930,882
     SHARES
     BENEFICIALLY      8   Shared Voting Power         -0-
     OWNED BY EACH
     REPORTING         9   Sole Dispositive Power      4,930,882
     PERSON
     WITH             10   Shared Dispositive Power    -0-

11   Aggregate Amount Beneficially Owned by Each Reporting
Person
     4,930,882

12   Check Box if the Aggregate Amount in Row 11 Excludes
Certain Shares
     [ ]

13   Percent of Class Represented by Amount in Row 11
     8.4%

14   Type of Reporting Person
     IA



CUSIP No. 86323X106	SCHEDULE 13D	Page 5 of 10



 1   Name of Reporting Person
     Tamarack Capital Management, LLC
     IRS Identification No. of Above Person	90-0292676
     (entities only)

 2   Check the Appropriate Box if a Member of a Group*  (a) [ ]
                                                        (b) [ ]

 3   SEC USE ONLY

 4   Source of Funds                                         WC

 5   Check Box if Disclosure of Legal Proceedings
     is Required Pursuant to Items 2(d) or 2(e)             [ ]

6   Citizenship or Place of Organization
     Delaware

     NUMBER OF         7   Sole Voting Power           4,930,882
     SHARES
     BENEFICIALLY      8   Shared Voting Power         -0-
     OWNED BY EACH
     REPORTING         9   Sole Dispositive Power      4,930,882
     PERSON
     WITH             10   Shared Dispositive Power    -0-

11   Aggregate Amount Beneficially Owned by Each Reporting
Person
     4,930,882

12   Check Box if the Aggregate Amount in Row 11 Excludes
Certain Shares
     [ ]

13   Percent of Class Represented by Amount in Row 11
     8.4%

14   Type of Reporting Person
     HC



CUSIP No. 86323X106	SCHEDULE 13D	Page 6 of 10



 1   Name of Reporting Person
     Tamarack Global Healthcare Fund, L.P.
     IRS Identification No. of Above Person	20-8297742
     (entities only)

 2   Check the Appropriate Box if a Member of a Group*  (a) [ ]
                                                        (b) [ ]

 3   SEC USE ONLY

 4   Source of Funds                                         WC

 5   Check Box if Disclosure of Legal Proceedings
     is Required Pursuant to Items 2(d) or 2(e)             [ ]

6   Citizenship or Place of Organization
     Delaware

     NUMBER OF         7   Sole Voting Power           4,223,334
     SHARES
     BENEFICIALLY      8   Shared Voting Power         -0-
     OWNED BY EACH
     REPORTING         9   Sole Dispositive Power      4,223,334
     PERSON
     WITH             10   Shared Dispositive Power    -0-

11   Aggregate Amount Beneficially Owned by Each Reporting
Person
     4,223,334

12   Check Box if the Aggregate Amount in Row 11 Excludes
Certain Shares
     [ ]

13   Percent of Class Represented by Amount in Row 11
     7.2%

14   Type of Reporting Person
     PN




CUSIP No. 86323X106	SCHEDULE 13D	Page 7 of 10


Item 1.   Security and Issuer

This Schedule 13D ("Schedule") relates to shares of Common
Stock, $0.01 par value (the "Common Stock"), of Streamline
Health Solutions Inc. (the "Issuer").  The principal executive
office of the Issuer is 2400 Old Milton Parkway, Box 1353,
Alpharetta, GA  30009.

Item 2.   Identity and Background

This Schedule is filed on behalf of the following entities:

Justin John Ferayorni, a United States Citizen.
Tamarack Capital GP, LLC, a Delaware limited liability company
("Tamarack GP")
Tamarack Advisers, LP, a Delaware limited partnership ("Tamarack
IA")
Tamarack Capital Management, LLC, a Delaware limited liability
company ("Tamarack PFGP")
Tamarack Global Healthcare Fund, L.P., a Delaware limited
partnership ("Tamarack GHF")

The business address of the reporting entities is 5050 Avenida
Encinas, Suite 360, Carlsbad, CA  92008.

Mr. Ferayorni's main occupation or employment is an investment
adviser representative with Tamarack Advisers, LP, a registered
investment adviser located at the address listed above.

Mr. Ferayorni is the sole owner of Tamarack GP, the general
partner of Tamarack IA, of which he also the sole limited
partner.

Mr. Ferayorni is the sole owner of Tamarack PFGP, the general
partner of Tamarack GHF.

Mr. Ferayorni has not, during the past five years, been
convicted of any criminal proceeding (excluding traffic
violations or similar misdemeanors).

None of the reporting entities have been a party to a civil
proceeding of a judicial or administrative body of competent
jurisdiction and as a result of such proceeding was or is
subject to a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject
to, federal or state securities laws or finding any violation
with respect to such laws.



CUSIP No. 86323X106	SCHEDULE 13D	Page 8 of 10


Item 3.   Source and Amount of Funds or Other Consideration

Funds for the purchases of Common Stock were obtained from the
working capital of the reporting entities, and Grants of
restricted stock from the issuer.

Item 4.   Purpose of Transaction.

The purchases of Common Stock were made solely for investment
purposes.  Depending upon market conditions and other factors,
the reporting entities may increase beneficial ownership of
securities of the Issuer, or alternatively, may dispose of some
or all of the securities of the Issuer that it beneficially
owns.

Item 5.   Interest in Securities of the Issuer

(a),(b)   Reference is made hereby to Items 7-11 and 13 of pages
          2 through 6 of this Schedule, which Items are
          incorporated by reference herein.

          The calculation of percentage of beneficial ownership
          in item 13 of pages 2 through 8 were derived from the
          Issuer's Form 10-Q filed with the Securities and
          Exchange Commission on June 30, 2023, in which
          The Issuer stated that the number of shares of Common
          Stock outstanding as of June 12, 2023 was
          58,641,313.

(c)       The acquisition of the shares by Justin Ferayorni
          was through a grant by Streamline Health Solutions
          Inc.


          Date               #of shares           Price
          ----------------   ----------------     $-------------
          06/15/2023           86,207              0.00




CUSIP No. 86323X106	SCHEDULE 13D	Page 9 of 10


(d)       No Other than the reporting persons, the additional
          private fund, for which Tamarack PFGP serves as
          general partner and Tamarack IA serves as investment
          adviser, and the owners of the family accounts managed
          by Mr. Ferayorni have the right to receive or the
          power to direct the receipt of dividends from, or the
          proceeds from, the sale of the common stock mentioned
          in item 1.

(e)       Not applicable.

Item 6.   Contracts, Arrangements, Understandings or
          Relationships with Respect to Securities of the Issuer

     None.

Item 7.   Material to be Filed as Exhibits

     None.


Signatures

After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete and correct.

DATED:  June 21, 2023

        Justin J. Ferayorni


        /s/ Justin J. Ferayorni
        ________________________
        By:     Justin J. Ferayorni
        Its:    Himself

        Tamarack Capital GP, LLC


        /s/ Justin J. Ferayorni
        ________________________
        By:     Justin J. Ferayorni
        Its:    Managing Member

        Tamarack Advisers, LP


        /s/ Justin J. Ferayorni
        ________________________
        By:     Justin J. Ferayorni
        Its:    Managing member of its general partner

Continued on next page



CUSIP No. 86323X106	SCHEDULE 13D	Page 10 of 10


Signatures (continued)

        Tamarack Capital Management, LLC


        /s/ Justin J. Ferayorni
        ________________________
        By:     Justin J. Ferayorni
        Its:    Managing member

        Tamarack Global Healthcare Fund, L.P.


        /s/ Justin J. Ferayorni
        ________________________
        By:     Justin J. Ferayorni
        Its:    Managing member of its general partner